Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

To Meet Demand, Forma Aims To Boost Discovery Supply

Jul 26 2013

• By Alex Lash

Related Content

The Next Big Thing In Drug Development May Be The Ubiquitin Pathway

Apr 01 2010

With Celgene Deal, Forma Makes First Foray Into Clinical Development

Apr 29 2013

Genentech Licenses A Cancer Metabolism Program From Forma, With Option To Buy

Jun 27 2011

New $80 Million U.K. Asset-Centric Cancer Research Fund Set Up With EU, Charity Funding

Mar 29 2012

Related Companies

Forma Therapeutics Inc.

Boehringer Ingelheim GmbH

Johnson & Johnson

Roche Holding AG

Genentech, Inc.

Bristol Myers Squibb Company

Cancer Research Horizons

Cancer Research UK

Takeda Pharmaceutical Co. Ltd.

Arteaus Therapeutics, LLC

Drais Pharmaceuticals, Inc.

Astellas Pharma, Inc.

City of Hope

Additional Topics

United States United Kingdom Europe Strategy Clinical Trials Business Strategies Platform Technologies Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window